Reduced thoracic skeletal muscle size is associated with adverse outcomes in diabetes patients with heart failure and reduced ejection fraction: quantitative analysis of sarcopenia by using cardiac MRI.

MLA

Shi, Ke, et al. “Reduced Thoracic Skeletal Muscle Size Is Associated with Adverse Outcomes in Diabetes Patients with Heart Failure and Reduced Ejection Fraction: Quantitative Analysis of Sarcopenia by Using Cardiac MRI.” Cardiovascular Diabetology, vol. 23, no. 1, Jan. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12933-023-02109-7.

APA

Shi, K., Zhang, G., Fu, H., Li, X.-M., Yu, S.-Q., Shi, R., Yan, W.-F., Qian, W.-L., Xu, H.-Y., Li, Y., Guo, Y.-K., & Yang, Z.-G. (2024). Reduced thoracic skeletal muscle size is associated with adverse outcomes in diabetes patients with heart failure and reduced ejection fraction: quantitative analysis of sarcopenia by using cardiac MRI. Cardiovascular Diabetology, 23(1), 1–10. https://doi.org/10.1186/s12933-023-02109-7

Chicago

Shi, Ke, Ge Zhang, Hang Fu, Xue-Ming Li, Shi-Qin Yu, Rui Shi, Wei-Feng Yan, et al. 2024. “Reduced Thoracic Skeletal Muscle Size Is Associated with Adverse Outcomes in Diabetes Patients with Heart Failure and Reduced Ejection Fraction: Quantitative Analysis of Sarcopenia by Using Cardiac MRI.” Cardiovascular Diabetology 23 (1): 1–10. doi:10.1186/s12933-023-02109-7.